Contract Development and Manufacturing Organization

Sai Life Sciences reported strong FY26 performance with revenue growth of 29% to ₹2,192 Cr and PAT surge of 105% to ₹349 Cr, driven by integrated CRDMO model execution. The company expanded to 19 of t